Haoma Medica completes first-in-human trial for NaQuinate

This article was originally published here

The first-in-human trial initiated last year in healthy adults studied single and multiple doses of NaQuinate. The primary objective was to assess the safety, tolerability and pharmacokinetics. ”We

The post Haoma Medica completes first-in-human trial for NaQuinate appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply